REG - BioPharma Credit PLC - Notice of Interim Results

Biopharma CreditAnnouncement

12/08/2019 07:05

RNS Number : 6203I
BioPharma Credit PLC
12 August 2019
 


12 August 2019
BIOPHARMA CREDIT PLC
("The Company") 
NOTICE OF INTERIM RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Half Year Results for the period ending 30 June 2019, on Wednesday 4 September 2019.
A management presentation will be held at 09:30am at Buchanan, 107 Cheapside, EC2V 6DN. A conference call facility will also be available.
To confirm your attendance, or request conference call details, RSVP to biopharmacredit@buchanan.uk.com.
-Ends-
Enquiries
 BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0) 1392 477 500
 
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOREKLFBKVFFBBK